Botswana Vaccine Institute

The Botswana Vaccine Institute (BVI) is a leading developer and manufacturer of high-quality veterinary vaccines, primarily focused on controlling transboundary animal diseases in Africa and the Middle East. Established in 1978 as a partnership between the Botswana government and Institut Mérieux, BVI specializes in Foot-and-Mouth Disease (FMD) vaccines tailored to specific regional strains. The institute operates a state-of-the-art manufacturing facility in Gaborone and serves as a regional reference laboratory for the World Organisation for Animal Health (WOAH). Its product portfolio includes vaccines for Rabies, Anthrax, Lumpy Skin Disease, and Peste des Petits Ruminants, supporting livestock health and international trade. BVI is recognized for its sophisticated antigen bank, which allows for rapid response to disease outbreaks.